Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.
暂无分享,去创建一个
G. Wilding | J. Cleary | K. Tutsch | R. Arzoomanian | D. Alberti | C. Feierabend | James P. Thomas | Amy Dresen | J. Merchant | K. Binger | Rebecca Marnoccha